Companies
/Healthcare
Baxter International Inc
$25.39
▲ $0.00 (+0.00%) today
Markets closed · 12:35am ET
Baxter International (BAX) Earnings History & Trends
67%
EPS beat rate
+12.47%
Avg. EPS surprise
Consecutive EPS beats
BAX vs Market · 30-day return after each reportBAXS&P 500
BAX EPS Trend · estimate vs actualEstimateActual
BAX Revenue Trend · estimate vs actualEstimateActual
How Often Does Baxter International Beat Earnings Estimates?
Baxter International beat EPS estimates in 4 of its last 6 reported quarters, and has beaten 3 quarters in a row.
| Quarter | EPS · est. | Surprise | Revenue · est. | Surprise |
|---|---|---|---|---|
| Q3 2026 Adjusted figure excludes a $253 million pre-tax gain on debt extinguishment ($0.38 per share), intangible amortization of $145 million pre-tax ($0.21), business optimization charges of $61 million ($0.09), business transformation costs of $20 million ($0.03), a $27 million net legal benefit ($0.04), and $41 million of tax matters ($0.08); GAAP diluted EPS was $0.57. | $0.58 est. $0.52 | +11.93% | $3.0B est. $2.9B | +2.33% |
| Q2 2026 | $0.56 est. $0.37 | +52.51% | $3.0B est. $2.8B | +5.88% |
| Q1 2026 | $0.36 est. $0.31 | +15.90% | $2.7B est. $2.6B | +3.27% |
| Q4 2025 | $0.44 est. $0.54 | −17.80% | $3.0B est. $2.8B | +5.28% |
| Q3 2025 | $0.69 est. $0.60 | +15.40% | $2.8B est. $2.9B | −1.47% |
| Q2 2025 | $0.59 est. $0.61 | −3.12% | $2.8B est. $2.8B | −0.45% |
Figures from SEC filings and company reports. Not investment advice.